Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Article CAS PubMed Google Scholar
Pohl P, Slepecki P, Spielauer M. STATSIM: Statistics Austria’s dynamic microsimulation model for official population projections. Statistical Journal of the IAOS. 2024;40(4):969–84. https://doi.org/10.1177/18747655241308058.
ESMO Handbook on Cancer in the Senior Patient, 2nd Edition, 2015
Li L, Shan T, Zhang D, Ma F. Nowcasting and forecasting global aging and cancer burden: analysis of data from the GLOBOCAN and Global Burden of Disease Study. J Natl Cancer Cent. 2024;4(3):223–32. https://doi.org/10.1016/j.jncc.2024.05.002.
Article PubMed PubMed Central Google Scholar
Wildiers H, Heeren P, Puts M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32(24):2595–603. https://doi.org/10.1200/JCO.2013.54.8347.
Article PubMed PubMed Central Google Scholar
Loh KP, Liposits G, Arora SP, et al. Adequate assessment yields appropriate care-the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group. ESMO Open. 2024;9(8)103657. https://doi.org/10.1016/j.esmoop.2024.103657.
Article CAS PubMed PubMed Central Google Scholar
Bergerot CD, Temin S, Verduzco-Aguirre HC, et al. Geriatric Assessment: ASCO Global Guideline. JCO Glob Oncol. 2025;11:e2500276. https://doi.org/10.1200/GO-25-00276.
Article PubMed PubMed Central Google Scholar
Dale W, Klepin HD, Williams GR, et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update. J Clin Oncol. 2023;41(26):4293–312. https://doi.org/10.1200/JCO.23.00933.
Article PubMed PubMed Central Google Scholar
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie. https://www.dgho.de/arbeitskreise/a-g/geriatrische-onkologie. Zugriff am 19 Oct 2025.
Deutsche Gesellschaft für Geriatrie e. V. (DGG). S3-Leitlinie „Umfassendes Geriatrisches Assessment (Comprehensive Geriatric Assessment, CGA) bei hospitalisierten Patientinnen und Patienten“. Langversion 1.1. 2024. https://register.awmf.org/de/leitlinien/detail/084-003. Accessed 19 Oct 2025.
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.
Article CAS PubMed Google Scholar
Karnofsky DABJ, Burchenal JOSEPH. Evaluation of chemotherpeutic agents. NY, New York: Columbia University; 1949.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. https://doi.org/10.1016/0021-9681(87)90171-8.
Article CAS PubMed Google Scholar
van Abbema DL, van den Akker M, Janssen-Heijnen ML, et al. Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: A systematic review. J Geriatr Oncol. 2019;10(1):31–41. https://doi.org/10.1016/j.jgo.2018.04.001.
Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457–65. https://doi.org/10.1200/JCO.2011.34.7625.
Article CAS PubMed PubMed Central Google Scholar
Hurria A, Mohile S, Gajra A, et al. Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer. J Clin Oncol. 2016;34(20):2366–71. https://doi.org/10.1200/JCO.2015.65.4327.
Article PubMed PubMed Central Google Scholar
Alibhai SM, Aziz S, Manokumar T, Timilshina N, Breunis H. A comparison of the CARG tool, the VES-13, and oncologist judgment in predicting grade 3+ toxicities in men undergoing chemotherapy for metastatic prostate cancer. J Geriatr Oncol. 2017;8(1):31–6. https://doi.org/10.1016/j.jgo.2016.09.005.
Ostwal V, Ramaswamy A, Bhargava P, et al. Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study. BMJ Open. 2021;11(6)e047376. https://doi.org/10.1136/bmjopen-2020-047376.
Article PubMed PubMed Central Google Scholar
Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer Cytopathol. 2012;118(13):3377–86. https://doi.org/10.1002/cncr.26646.
Rosko AE, Huang Y, Wall SA, et al. Predictive ability of the Cancer and Aging Research Group chemotherapy toxicity calculator in hematologic malignancy. J Geriatr Oncol. 2025;16(1)102144. https://doi.org/10.1016/j.jgo.2024.102144.
Article CAS PubMed Google Scholar
Magnuson A, Loh KP, Stauffer F, et al. Geriatric assessment for the practicing clinician: The why, what, and how. CA Cancer J Clin. 2024;74(6):496–518. https://doi.org/10.3322/caac.21864.
Article PubMed PubMed Central Google Scholar
Loh KP, Mohile SG, Epstein RM, et al. Willingness to bear adversity and beliefs about the curability of advanced cancer in older adults. Cancer Cytopathol. 2019;125(14):2506–13. https://doi.org/10.1002/cncr.32074.
Article PubMed PubMed Central Google Scholar
Soto-Perez-de-Celis E, Dale W, Katheria V, et al. Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial. Cancer Cytopathol. 2024;130(17):3000–10. https://doi.org/10.1002/cncr.35333.
Article PubMed PubMed Central Google Scholar
Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346(14):1061–6. https://doi.org/10.1056/NEJMsa012528.
Hamaker M, Lund C, Te Molder M, et al. Geriatric assessment in the management of older patients with cancer - A systematic review (update). J Geriatr Oncol. 2022;13(6):761–77. https://doi.org/10.1016/j.jgo.2022.04.008.
Article CAS PubMed Google Scholar
Anwar MR, Yeretzian ST, Ayala AP, et al. Effectiveness of geriatric assessment and management in older cancer patients: a systematic review and meta-analysis. JNCI Cancer Spectr. 2023;115(12):1483–96. https://doi.org/10.1093/jnci/djad200.
Dale W, Williams GR, R MacKenzie A, et al. How Is Geriatric Assessment Used in Clinical Practice for Older Adults With Cancer? A Survey of Cancer Providers by the American Society of Clinical Oncology. JCO Oncol Pract. 2021;17(6):336–44. https://doi.org/10.1200/OP.20.00442.
Soubeyran P, Bellera C, Goyard J, et al. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study. PLoS One. 2014;9(12)e115060. https://doi.org/10.1371/journal.pone.0115060.
Article CAS PubMed PubMed Central Google Scholar
Williams G, et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Questions and Answers. JCO Oncol Pract. 2023;19:718–23. https://doi.org/10.1200/OP.23.00263.
Comments (0)